Cara Therapeutics, Inc. (CARA) Reports Positive Top-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845
Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today announced positive top-line data from the adaptive Phase 2/3 trial of I.V. CR845 in patients undergoing abdominal surgeries. At the... Read more
This Marijuana Stock is Poised to Benefit from Legal Cannabis Boom!
Unless you’ve been in a deep sleep, the marijuana industry has gotten a huge boost this year, which could spell huge first mover advantage right now. Canada’s recent nationwide legalization for recreational marijuana has posed a massive opportunity and marijuana stocks are in the spotlight for good reason right... Read more
The Green Organic Dutchman Holdings Ltd. (TGOD) (TGODF) ANNOUNCES CLOSING OF $25 MILLION SPECIAL WARRANT BOUGHT DEAL FINANCING
THE GREEN ORGANIC DUTCHMAN ANNOUNCES CLOSING OF $25 MILLION SPECIAL WARRANT BOUGHT DEAL FINANCING The Green Organic Dutchman Holdings Ltd. has closed its bought deal financing of 3.91 million special warrants of the company at $6.40 per special warrant for aggregate gross proceeds of approximately $25-million, previously announced on... Read more
2 Canadian Marijuana Stocks To Watch This Quarter
The marijuana industry has continued to astound investors as new companies have continued to come to light attracting a myriad of investors into the space. Because of the new legislation and the changing public sentiment toward the favor of cannabis, many new companies have come to light over the... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )